Evaluation of Elispot assays: Influence of method and operator on variability of results

Journal of Immunological Methods

Volumn 291, Issue 1-2, 2004, Pages 175-183

  Janetzki, S ^a   Schaed, S ^b,c   Blachere, N E B ^b,d   Ben Porat, L ^b   Houghton, A N ^b   Panageas, K S ^b  

^a ZellNet Consulting Inc   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Elispot; Elispot plate evaluation; Standardization

Indexed keywords

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; EVALUATION; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMAGING SYSTEM; INTERMETHOD COMPARISON; LABORATORY AUTOMATION; MICROSCOPE; PRIORITY JOURNAL; RANDOMIZATION; REPRODUCIBILITY; STANDARDIZATION; STEREOMICROSCOPY; VALIDATION PROCESS;

HUMANS; IMMUNOENZYME TECHNIQUES; INTERFERON TYPE II; LABORATORY PERSONNEL; REPRODUCIBILITY OF RESULTS;

EID: 4444288678     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2004.06.008     Document Type: Article

References (32)

1. T. Asai, W.J. Storkus, and T.L. Whiteside Evaluation of the modified ELISPOT assay for gamma interferon production in cancer patients receiving antitumor vaccines Clin. Diag. Lab. Immunol. 7 2000 145
2. D. Atanackovic, M. Matsuo, E. Ritter, G. Mazzarea, G. Ritter, E. Jaeger, A. Knuth, O.J. Lloyd, and S. Gnjatic Monitoring CD4+ T cell responses against viral and tumor antigens using T cells as novel target APC J. Immunol. Methods 278 2003 57
3. C.M. Britten, R.G. Meyer, T. Kreer, I. Drexler, T. Woelfel, and W. Herr The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8+ T lymphocytes in IFN-gamma Elispot assays J. Immunol. Methods 259 2002 95
4. T.M. Clay, A.C. Hobeika, P.J. Mosca, K. Lyerly, and M.A. Morse Assays for monitoring cellular immune responses to active immunotherapy of cancer Clin. Cancer Res. 7 2001 1127
5. J.H. Cox, G. Ferrari, S.A. Kalams, W. Lopaczynski, N. Oden, P. D'Souza Elispot Collaborative Study Group Results of an ELISPOT Proficiency Panel conducted in 11 laboratories participating in international human immunodeficiency virus Type 1 vaccine trials AIDS Res. & Hu Retroviruses 2004 (in press)
6. Y. Cui, and L.-J. Chang Computer-assisted, quantitative cytokine enzyme-linked immunospot analysis of human immune effector cell function Biotechniques 22 1997 1146
7. J.R. Currier, E.G. Kuta, E. Turk, L.B. Earhart, L. Loomis-Price, S. Janetzki, G. Ferrari, D.B. Birx, and J.H. Cox A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial Elispot assays J. Immunol. Methods 260 2002 157
8. C.C. Czerkinsky, L.A. Nilsson, H. Nygren, O. Ouchterlony, and A. Tarkowski A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells J. Immunol. Methods 65 1983 109
9. C. Czerkinsky, G. Andersson, H.-P. Ekre, L.-A. Nilsson, L. Klaresgog, and O. Ouchterlony Reverse ELISPOT assay for clonal analysis of cytokine production: I. Enumeration of gamma-interferon-secreting cells J. Immunol. Methods 110 1988 29
10. W. Herr, B. Linn, N. Leister, E. Wandel, K.-H. Meyer zum Bueschenfelde, and T. Woelfel The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha in response to peptide antigens J. Immunol. Methods 203 1997 141
11. M.D. Hesse, A.Y. Karulin, B.O. Boehm, P.V. Lehmann, and M. Tary-Lehmann A T cell clone's avidity is a function of its activation state J. Immunol. 167 2001 1353
12. H. Hoerig, D.S. Lee, W. Conkright, J. Divito, H. Hasson, M. LaMare, A. Rivera, D. Park, J. Tine, K. Guito, K.W.-Y. Tsang, J. Sclom, and H.L. Kaufman PhaseI clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 costimulatory molecule Cancer Immunol. Immunother. 49 2000 504
13. S. Janetzki, D. Palla, V. Rosenhauer, H. Lochs, J.J. Lewis, and P.K. Srivastava Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study Int. J. Cancer 88 2000 232
14. S. Janetzki, P. Song, V. Gupta, J.J. Lewis, and A.N. Houghton Insect cells as HLA-restricted antigen-presenting cells for the IFN-gamma Elispot assay J. Immunol. Methods 234 2000 1
15. S. Janetzki, J. Cox, N. Oden, and G. Ferrari Standardization and validation issues of the ELISPOT assay Handbook of ELISPOT: Methods and Protocols 2004 Humana Press NJ, USA (in press)
16. A.Y. Karulin, M.D. Hesse, M. Tary-Lehmann, and P.V. Lehmann Single-cytokine-producing CD4 memory cells predominate in type 1 and type 2 immunity J. Immunol. 164 2000 1862
17. J.L. Lathey Preliminary steps toward validating a clinical bioassay. A case study of the Elispot assay Biopharm Int. 2003 42
18. C.E. Lewis, D. McCracken, R. Ling, P.S. Richards, S.P. McCarthy, and J.O. McGee Cytokine release by single, immunophenotyped human cells: use of the reverse hemolytic plaque assay Immunol. Rev. 119 1991 23
19. J.J. Lewis, S. Janetzki, S. Schaed, K.S. Panageas, S. Wang, L. Williams, M. Meyers, L. Butterworth, P.O. Livingston, P.B. Chapman, and A.N. Houghton Evaluation of CD8+ T cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide Int. J. Cancer 87 2000 391
20. R.R. MacGregor, R. Ginsberg, K.E. Ugen, Y. Baine, C.U. Kang, X.M. Tu, T. Higgins, D.B. Weiner, and J.D. Boyer T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev AIDS 16 2002 2137
21. N. Meidenbauer, D.T. Harris, L.E. Spitler, and T.L. Whiteside Generation of PSA-specific effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer Prostate 43 2000 88
22. R.B. Moss, E. Webb, W.K. Giermakowska, F.C. Jensen, J.R. Savary, M.R. Wallace, and D.J.C. Nocola HIV-1-specific CD4 helper function in persons with chronic HIV-1 infection on antiviral drug therapy as measured by ELISPOT after treatment with an inactivated, gp120-depleted HIV-1 in incomplete Freund's adjuvant J. Acquir. Immune Defic. Syndr. 24 2000 264
23. M. Mwau, A.J. McMichael, and T. Hanke Design and validation of an enzyme-linked immunospot assay for use in clinical trials of candidate HIV vaccines AIDS Res. Hum. Retrovir. 18 2002 611
24. A.C. Peterson, H. Harlin, and T.F. Gajewski Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma J. Clin. Oncol. 21 2003 2342
25. F. Rahman, A. Dahmen, S. Herzog-Hauff, W.O. Boecher, P.R. Galle, and H.F. Loehr Cellular and humoral immune responses induced by indradermal or intramuscular vaccination with the major Hepatitis B surface antigen Hepatology 31 2000 521
26. S.G. Schaed, V.M. Klinek, K.S. Panageas, C.M. Musselli, L. Butterworth, W.J. Hwu, P.O. Livingston, L. Williams, J.J. Lewis, A.N. Houghton, and P.B. Chapman T-cell responses against tyrosinase 368â€"376(370D) peptide in HLA(*)A0201(+) melanoma patients: randomized trial comparing incomplete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, and QS-21 as immunological adjuvants Clin. Cancer Res. 8 2002 967
27. C. Scheibenbogen, P. Romero, L. Rivoltini, W. Herr, A. Schmittel, J.-C. Cerottini, T. Woelfel, A.M.M. Eggermont, and U. Keilholz Quantification of antigen-reactive T cells in peripheral blood by IFN-gamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial J. Immunol. Methods 244 2000 81
28. A. Schmittel, U. Keilholz, S. Bauer, U. Kuhne, S. Stevanovic, E. Thiel, and C. Scheibenbogen Application of the IFN-gamma ELISPOT assay to quantify T cell responses against proteins J. Immunol. Methods 247 2001 17
29. J.G. Smith, X. Liu, R.M. Kaufhold, J. Clair, and M.J. Caulfield Development and validation of a gamma interferon ELISPOT assay for quantification of cellular immune responses to varizello-zoster virus Clin. Diag. Lab. Immunol. 8 2001 871
30. P. Thumann, I. Moc, J. Humrich, T.G. Berger, E.S. Schultz, G. Schuler, and L. Jenne Antigen loading of dendritic cells with whole tumor cell preparations J. Immunol. Methods 277 2003 1
31. J.E. Vaquerano, M. Peng, J.W.C. Chang, Y.-M. Zhou, and S.P.L. Leong Digital quantification of the enzyme-linked immunospot (ELISPOT) Biotechniques 25 1998 830
32. F. Wang, E. Bade, C. Kuniyoshi, L. Spears, G. Jeffery, V. Marty, S. Groshen, and J. Weber Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma Clin. Cancer Res. 5 1999 2756